The IV catheters market was valued at $8.6 billion in 2022 and is estimated to reach $17.8 billion by 2032, exhibiting a CAGR of 7.5% from 2023 to 2032. An intravenous (IV) catheter, also known as an IV line or IV cannula, is a medical device used to administer fluids, medications, or blood products directly into a patient’s bloodstream. It consists of a thin, flexible tube typically made of plastic or other biocompatible materials with a sharp needle or catheter at one end. The needle is used to puncture a vein, and once the catheter is in place, the needle is removed, leaving the catheter securely in the vein.
The major factors driving the growth of the IV catheters market are the increase in the number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV catheters. The surge in prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, and infectious diseases drives the demand for IV catheters. Intravenous administration allows for the direct and efficient delivery of medications, fluids, and nutrition, making it a crucial treatment method for patients with chronic conditions.
In addition, ongoing technological advancements in IV catheter designs, materials, insertion techniques, and related medical equipment have made IV therapy more efficient, comfortable, and safe, which is expected to drive the market growth. Innovations encourage healthcare providers to utilize IV catheters for a broader range of treatments, further driving the market expansion.
Further, the trend toward home-based healthcare and outpatient services has increased the use of IV catheters outside traditional hospital settings, thereby driving the market growth. Patients with chronic conditions or those requiring post-operative care may receive IV therapy at home, leading to higher demand.
However, the risk of complications and infections and stringent regulatory requirements are the factors that hamper the growth of IV catheters market. The use of intravenous equipment carries a certain degree of risk, including the potential for complications and infections. Improper insertion, handling, or maintenance of IV catheters may lead to catheter-related bloodstream infections (CRBSIs) or other complications such as phlebitis or infiltration, thereby restraining the market growth. However, the growing aging population, increase in surgical procedures, and rise in technological advancements are expected to offer opportunities to the key players of the market.
The IV catheters market is segmented into product, type, end user, and region. By product, the market is classified into 18 G, 20G, 22G, 24 G, and others. By type, the market is classified into peripheral IV catheters, central venous catheters, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Malaysia, Thailand, Philippines, Singapore, Indonesia, Vietnam, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global IV catheters market are Becton Dickinson & Company, B Braun SE, AngioDynamics, Inc., Terumo Corporation, Poly Medicure Ltd., Teleflex Incorporated, Vygon, BL Group of Companies, and ICU Medical Inc. Key players operating in the market have adopted acquisition, product launch and others as their key strategies to expand their product portfolio.

KEY BENEFITS FOR STAKEHOLDERS
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the iv catheters market analysis from 2022 to 2032 to identify the prevailing iv catheters market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the iv catheters market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global iv catheters market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client’s interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)

KEY MARKET SEGMENTS
By Product
- 18G
- 20G
- 22G
- 24G
- Others

By Type
- Others
- Peripheral IV Catheters
- Central Venous Catheters

By End Users
- Hospitals
- Ambulatory Surgical Centers
- Others

By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Malaysia
- Thailand
- Philippines
- Singapore
- Indonesia
- Vietnam
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- ICU Medical Inc.
- Terumo Corporation
- Vygon
- Becton, Dickinson and Company
- Nipro Corporation
- B. Braun SE
- AngioDynamics, Inc.
- Teleflex Incorporated
- Poly Medicure Ltd.
- BL Group of Companies